Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

Overview of attention for article published in Journal of Translational Medicine, October 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 91 Dimensions

Readers on

mendeley: 38 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

ULK1 inhibitors and methods using same

Application US-10266549-B2

United States of America

METHODS OF IDENTIFYING PATIENTS SUFFERING FROM CANCER AND TREATING CANCER IN PATIENTS…

Application EA-030276-B1

Eurasian Patent Organisation

NOVEL ULK1 INHIBITORS AND METHODS USING SAME

Application WO-2016033100-A1

World Intellectual Property Organisation (WIPO)

METHODS OF DIAGNOSING AND TREATING CANCER IN PATIENTS HAVING OR DEVELOPING RESISTANCE TO…

Application WO-2011112678-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.